Sign in
4

Changes in Ownership

Corbus Pharmaceuticals Holdings, Inc. Filed Acc 0001209191-16-121472

Chief Financial Officer bought 27,250 shares at $2.37 ($64,583)

From the SEC's structured data for this filing

Trades in this filing

Moran Sean F. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2016-05-19 Purchase : show line 1 in the form +27,250 $2.37 $64,583 132,450 D
Open-market purchases · 27,250 sh · avg $2.37 · $64,583
Loading xslF345X03/doc4.xml…